These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16157930)

  • 1. MuSK Antibody-Positive Myasthenia Gravis With SARS CoV-2 Infection: A Case Report and Literature Review.
    Jha S; Pendyala SK
    J Clin Neuromuscul Dis; 2024 Jun; 25(4):203-205. PubMed ID: 38771234
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating microRNA plasma profile in MuSK+ myasthenia gravis.
    Sabre L; Guptill JT; Russo M; Juel VC; Massey JM; Howard JF; Hobson-Webb LD; Punga AR
    J Neuroimmunol; 2018 Dec; 325():87-91. PubMed ID: 30316681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis: the future is here.
    Kaminski HJ; Sikorski P; Coronel SI; Kusner LL
    J Clin Invest; 2024 Jun; 134(12):. PubMed ID: 39105625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis with Microscopic Thymoma.
    Banerjee A; Nathoo N; Purdy K; Puznak K; Siddiqi Z; Zochodne DW
    Can J Neurol Sci; 2024 May; 51(3):435-437. PubMed ID: 37066702
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod.
    Zhu G; Ma Y; Zhou H; Nie X; Qi W; Hao L; Guo X
    Front Immunol; 2024; 15():1401972. PubMed ID: 38911858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Seropositive and Seronegative Myasthenia During Pregnancy Requires Appropriate Design and Diagnostic Testing.
    Finsterer J
    J Clin Neuromuscul Dis; 2024 Jun; 25(4):200-201. PubMed ID: 38771231
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis: MuSK MG, late-onset MG and ocular MG.
    Deymeer F
    Acta Myol; 2020 Dec; 39(4):345-352. PubMed ID: 33458590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-Specific Kinase Myasthenia Gravis.
    Borges LS; Richman DP
    Front Immunol; 2020; 11():707. PubMed ID: 32457737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: a clinical-immunological update.
    Binks S; Vincent A; Palace J
    J Neurol; 2016 Apr; 263(4):826-34. PubMed ID: 26705120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B; Schilling S; Zierz S
    J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies to agrin in myasthenia gravis patients.
    Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
    PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of MuSK-Associated Myasthenia Gravis.
    El-Salem K; Yassin A; Al-Hayk K; Yahya S; Al-Shorafat D; Dahbour SS
    Curr Treat Options Neurol; 2014 Apr; 16(4):283. PubMed ID: 24504626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.
    Oh SJ
    J Clin Neurol; 2009 Jun; 5(2):53-64. PubMed ID: 19587811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Saka E; Topcuoglu MA; Akkaya B; Galati A; Onal MZ; Vincent A
    Neurology; 2005 Sep; 65(5):782-3; author reply 782-3. PubMed ID: 16157930
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dropped head syndrome as prominent clinical feature in MuSK-positive Myasthenia Gravis with thymus hyperplasia.
    Spengos K; Vassilopoulou S; Papadimas G; Tsivgoulis G; Karandreas N; Zambelis T; Manta P
    Neuromuscul Disord; 2008 Feb; 18(2):175-7. PubMed ID: 18053719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.